The SPDR Health Care Select Sector SPDR Fund (XLV), a Large-Cap Low Volatility ETF, is heavily concentrated in the Healthcare sector, particularly Biotechnology & Drugs. An analysis of its fundamental factor exposures reveals a strong tilt towards Quality (score of 84) and an exceptionally high exposure to Low Volatility (score of 98), while exhibiting significantly lower scores for Value (26) and Momentum (36).
The SPDR Health Care Select Sector SPDR Fund (XLV) is characterized as a Large-Cap Low Volatility ETF, with its portfolio heavily concentrated within the Healthcare sector, specifically Biotechnology & Drugs. This indicates a targeted exposure to a segment known for both defensive characteristics and innovation. The Validea report provides a detailed fundamental factor analysis, offering insights into its underlying investment strategy. XLV exhibits an exceptionally high exposure to Low Volatility, scoring 98, and strong Quality characteristics, with a score of 84. This suggests a portfolio composed of stable companies with robust fundamentals. Conversely, the ETF shows significantly lower exposure to Value (score of 26) and Momentum (score of 36), indicating that its construction does not prioritize undervalued assets or those with recent strong price trends. This distinct factor profile positions XLV as a potential allocation for investors seeking stability and capital preservation within the healthcare industry. The emphasis on high quality and low volatility implies a focus on established companies that may offer resilience during periods of market uncertainty, rather than aggressive growth or turnaround plays.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
